These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23427811)

  • 1. Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials.
    Nikolic D; Nikfar S; Salari P; Rizzo M; Ray KK; Pencina MJ; Mikhailidis DP; Toth PP; Nicholls SJ; Rysz J; Abdollahi M; Banach M;
    Curr Med Res Opin; 2013 May; 29(5):435-51. PubMed ID: 23427811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
    Nikolic D; Banach M; Nikfar S; Salari P; Mikhailidis DP; Toth PP; Abdollahi M; Ray KK; Pencina MJ; Malyszko J; Rysz J; Rizzo M;
    Int J Cardiol; 2013 Oct; 168(6):5437-47. PubMed ID: 24016544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
    Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
    Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials.
    Karami J; Razi B; Imani D; Aslani S; Pakjoo M; Fasihi M; Mohammadi K; Sahebkar A
    Curr Pharm Des; 2024; 30(5):362-376. PubMed ID: 38288799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of statin therapy in maintenance dialysis patients.
    Sun L; Zou L; Chen M; Liu B
    Ren Fail; 2015 Aug; 37(7):1149-56. PubMed ID: 26139229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.
    Banach M; Dinca M; Ursoniu S; Serban MC; Howard G; Mikhailidis DP; Nicholls S; Lip GYH; Glasser S; Martin SS; Muntner P; Rysz J; Toth PP; Sahebkar A;
    Pharmacol Res; 2016 Sep; 111():343-356. PubMed ID: 27350264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients.
    Talavera JO; Martinez G; Cervantes JL; Marin JA; Rodriguez-Briones I; Gonzalez JG; Ocampo R; Sanchez-Mijangos H; Bernal-Rosales LP; Polanco A
    Curr Med Res Opin; 2013 Apr; 29(4):379-86. PubMed ID: 23323877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Lin YC; Lai TS; Wu HY; Chou YH; Chiang WC; Lin SL; Chen YM; Chu TS; Tu YK
    Clin Pharmacol Ther; 2020 Oct; 108(4):833-843. PubMed ID: 32320058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):219-26. PubMed ID: 23324122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
    Ribeiro S; Faria Mdo S; Silva G; Nascimento H; Rocha-Pereira P; Miranda V; Vieira E; Santos R; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
    Hemodial Int; 2012 Oct; 16(4):481-90. PubMed ID: 22515595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in chronic kidney disease: cardiovascular risk and kidney function.
    Deedwania PC
    Postgrad Med; 2014 Jan; 126(1):29-36. PubMed ID: 24393749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials.
    Gao L; Zhao FL; Li SC
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):367-75. PubMed ID: 22639397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.